دورية أكاديمية
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
| العنوان: | Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study |
|---|---|
| المؤلفون: | McFarlane, Joshua J., Kochenderfer, Mark D., Olsen, Mark R., Bauer, Todd M., Molina, Ana, Hauke, Ralph J., Reeves, James A., Babu, Sunil, Van Veldhuizen, Peter, Somer, Bradley, Gunuganti, Vijay, Schnadig, Ian, George, Saby, Page, Ray D., Arrowsmith, Edward, Jain, Rohit K., Zhang, Joshua, McHenry, M. Brent, Johansen, Jennifer L., Vogelzang, Nicholas J. |
| المساهمون: | Bristol-Myers Squibb Company, Daiichi-Sankyo, Medpacto, Incyte, Mirati Therapeutics, MedImmune, AbbVie, AstraZeneca, MabVax, Stemline Therapeutics, Merck, Lilly, GlaxoSmithKline, Novartis, Genentech, Deciphera, Merrimack, Immunogen, Millennium, Phosplatin Therapeutics, Calithera Biosciences, Kolltan Pharmaceuticals, Principa Biopharma, Peloton Pharmaceuticals, Immunocore, Roche, Aileron Therapeutics, Amgen, Onyx, Sanofi, Boehringer Ingelheim, Astellas Pharma, Five Prime Therapeutics, Jacobio, Top Alliance BioScience, Janssen, Clovis Oncology, Takeda, Karyopharm Therapeutics, Foundation Medicine, ARMO Biosciences, Pfizer, Loxo, Sarah Cannon Research Institute, Eli Lilly, Tesaro, TG Therapeutics, Celgene, BMS, Boston Biomedical Inc, Novocure, Guardant Health, Acerta Pharma, Rhizen Pharmaceuticals, Takeda Pharmaceuticals, Onconova Therapeutics, CTI Biopharma, Bayer, Corvus, Acceleron, Agensys, Eisai |
| المصدر: | Clinical Genitourinary Cancer ; volume 18, issue 6, page 469-476.e4 ; ISSN 1558-7673 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Urology, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.clgc.2020.06.002 |
| الإتاحة: | https://doi.org/10.1016/j.clgc.2020.06.002Test https://api.elsevier.com/content/article/PII:S1558767320301415?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1558767320301415?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.F81D12F7 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.clgc.2020.06.002 |
|---|